Summary for 9MD7
| Entry DOI | 10.2210/pdb9md7/pdb |
| Descriptor | Protease, N-(dihydroxymethyl)-L-phenylalanyl-N-[(2R,3S)-2-hydroxy-1-methoxy-5-methyl-1-oxohexan-3-yl]-L-lysinamide (3 entities in total) |
| Functional Keywords | tuberculosis, protease inhibitor, rv2224c/caea/hip1, hydrolase, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
| Biological source | Mycobacterium tuberculosis |
| Total number of polymer chains | 1 |
| Total formula weight | 52713.95 |
| Authors | Yim, M.K.,Olsen, K.J.,Brooks, C.L.,Pena, K.J.,Johnson, S.J.,Goldfarb, N.E. (deposition date: 2024-12-05, release date: 2025-12-17) |
| Primary citation | Schumann, N.C.,Harris, H.T.,Rouse Salcido, E.M.,Brooks, C.L.,Pena, K.J.,Karakousis, P.C.,Abell, A.D.,Olsen, K.J.,Yim, M.K.,Johnson, S.J.,Goldfarb, N.E. Discovery of Highly Potent alpha-Keto Ester-Based Peptidomimetic Inhibitors of the Hip1 Protease for the Treatment of Mycobacterium tuberculosis To Be Published, |
| Experimental method | X-RAY DIFFRACTION (2.72 Å) |
Structure validation
Download full validation report






